Selected Presentations
Molecular and functional neuroimaging in clinical neurosciences.
Lanzenberger, 16.06.2012
Dongzhimen Hospital affiliated to Beijing University of Chinese Medicine, Beijing, China.
![Functional Neuroimaging - PET & fMRI Functional Neuroimaging - PET & fMRI](./img/LAR_Bejing3.jpg)
PET in imaging genetics
Lanzenberger, 17.01.2012
8th Annual International Imaging Genetics Conference
The Beckman Center of the National Academy of Sciences in Irvine, 16-17 Jan. 2012, California, USA
Effects of SSRI administration on 5-HT1A BP, 5-HTT occupancy, and neural activation ([11C]WAY PET, [11C]DASB PET, phfMRI, multimodal)
Lanzenberger, 02.06.2009
METPETS Consortium - Inaugural Meeting Measuring Endogenous Neurotransmitters by PET and SPECT
Carlsberg Akademi, June 2-3 2009, Valby, Copenhagen, Denmark
Hormones and the Brain
23. April 2008: PD Dr. Lanzenberger's talk at the "Gesellschaft der Ärzte in Wien" (Billrothhaus)
Serotonin in anxiety and affective disorders
Lanzenberger, 09.04.2009
European Psychiatric Association (EPA) Meeting "Brain, Behaviour and Genes", April 9th - 10th 2009, Old College, Edinburgh, GB
Multimodal neuroimaging by combining PET and functional MRI
Lanzenberger, 03.03.2009
International Research Training Group (IRTG) Meeting
Klinik für Psychiatrie und Psychotherapie der RWTH , Aachen, Germany
Talks 2011
- Treatment effects of SSRIs on serotonergic neurotransmission in depression and anxiety disorders
Lanzenberger, x.09.2011
Symposium: Imaging the Serotonergic Transmitter System in Humans: A Multimodality Approach
24th ECNP Congress, 3-7 September 2011, Paris, France - Imaging the serotonergic system
Lanzenberger, 1x.03.2011
Core Symposium: Neuroimaging as a diagnostic tool
19th European Congress of Psychiatry (EPA), 12-15 March 2011, Vienna, Austria - The molecular and functional network in SSRI treatment
Lanzenberger, 1x.03.2011
Symposium: Molecular Systems Biology in Psychiatric Disorders
19th European Congress of Psychiatry (EPA), 12-15 March 2011, Vienna, Austria
Talks 2010
- How antidepressants change emotional processing in depressed patients?
Stein
Symposium: Integration of emotional processing in the treatment of depression
23rd ECNP Congress, 28 Aug - 1 Sept 2010, Amsterdam, Netherlands - Mechanisms of antidepressants and their dynamics
Lanzenberger, Kasper, 07.05.2010
Systems Biology of Affective Disorders, 6th International Workshop on Computational Neuropsychiatry, 7-8 May 2010, München, Germany - Molekulare und Funktionelle Bildgebung bei Therapie mit Selektiven Serotonin-Wiederaufnahmehemmern (PET, fMRT)
Lanzenberger, Kasper, 18.03.2010
54. Jahrestagung der Deutschen Gesellschaft für Klinische Neurophysiologie und Funktionelle Bildgebung (DGKN), 18-20 March 2010, Halle, Germany - Influence of escitalopram treatment on serotonin-1A receptor binding in anxiety disorders
Lanzenberger, 16.01.2010
Mallinckrodt - ÖGN Förderpreis Nuklearmedizin, Preisrede
29th International Symposium "Radioactive Isotopes in Clinical Medicine and Research", 16-19 Jan 2010, Bad Hofgastein, Austria
Talks 2009
- Multimodal neuroimaging by combining PET and functional MRI
Lanzenberger, 26.11.2009
Symposium Advanced MR-Imaging
DGPPN Kongress (Deutsche Gesellschaft für Psychiatrie, Psychotherapie und Nervenheilkunde), 25.-28.11.2009, Berlin, Germany - Molecular Imaging in der Psychiatrie
Lanzenberger, 03.10.2009
Symposium anlässlich der Installation eines PET/CT-Scanners
LKH Feldkirch, Austria - Imaging genetics: Putative Role in Clinical Psychiatry
Lanzenberger (PET), Pezawas (fMRI, sMRI), 13.09.2009
Brainstorming Session
22nd ECNP Congress, 12-16 September 2009, Istanbul, Turkey - Serotonin-1A receptor binding potential in dorsal raphe nuclei predicts orbitofrontal reactivity in healthy subjects
Hahn, 13.09.2009
Young Scientists Award Symposium 1
22nd ECNP Congress, 12-16 September 2009, Istanbul, Turkey - Effects of SSRIs on brain serotonin function revealed by PET and phfMRI
Lanzenberger, 29.06.2009
Symposium: Positron emission tomography (PET) and functional magnetic resonance imaging (fMRI) of human brain monoamine neurotransmission.
9th World Congress of Biological Psychiatry (WFSBP), 28 June - 2 July 2009, Paris, France - Amygdala hyperactivity in social anxiety disorder induced by facial attractiveness
Hahn, 28.06.2009
Young Scientist Award Session
9th World Congress of Biological Psychiatry (WFSBP), 28 June - 2 July 2009, Paris, France - Neuroimaging findings in psychiatric disorders (Opening Lecture)
Lanzenberger, 10.06.2009
XIV Konference Biologické Psychiatrie, 10 - 13 june 2009, Luhacovice, Czech Republic - Effects of SSRI administration on 5-HT1A BP, 5-HTT occupancy, and neural activation ([11C]WAY PET, [11C]DASB PET, phfMRI, multimodal)
Lanzenberger, 02.06.2009
METPETS Consortium - Inaugural Meeting Measuring Endogenous Neurotransmitters by PET and SPECT
Carlsberg Akademi, June 2-3 2009, Valby, Copenhagen, Denmark - 5HT in anxiety and affective disorders
Lanzenberger, 09.04.2009
European Psychiatric Association (EPA) Meeting „Brain, Behaviour and Genes“
April 9th - 10th 2009, Old College, Edinburgh, GB - Serotonin in anxiety and affective disorders
Lanzenberger, 08.04.2009
Invited Lecture at the Wolfson Molecular Imaging Centre, University of Manchester, GB - Wird die präfrontale Aktivität durch die Serotonin-1A Rezeptoren im dorsalen Raphenukleus moduliert?
Lanzenberger, 16.03.2009
WINTERSEMINAR "BIOLOGISCHE PSYCHIATRIE", 15.-21. März 2009, Oberlech, Austria - Aggression und frontale Serotonin-1A Rezeptorbindung
Savli, 16.03.2009
WINTERSEMINAR "BIOLOGISCHE PSYCHIATRIE", 15.-21. März 2009, Oberlech, Austria - Serotonin-1A receptor binding potential in dorsal raphe nuclei predicts orbitofrontal reactivity in healthy subjects
Hahn, 06.03.2009
ECNP Workshop on Neuropsychopharmacology for Young Scientists in Europe, 5 - 8 March 2009, Nice, France - Multimodal neuroimaging by combining PET and functional MRI
Lanzenberger, 03.03.2009
International Research Training Group (IRTG) Meeting
Klinik für Psychiatrie und Psychotherapie der RWTH , Aachen, Germany - Neuroimaging der Depression: Relevanz für die Praxis?
Lanzenberger, 28.02.2009
Fortbildungsreihe - Psychiatrie in Wissenschaft und Praxis
MUW, Vienna, Austria
Talks 2008
- Changes in binding of serotonin-1A receptor and serotonin transporter by SSRI treatment revealed with PET
Lanzenberger, 10.10.2008
7. Drei-Länder-Symposiums für Biologische Psychiatrie
9. - 11. Oktober 2008, Göttingen, Germany - Multimodal neuroimaging in anxiety disorders by combining PET and functional MRI
Lanzenberger, 10.10.2008
7. Drei-Länder-Symposiums für Biologische Psychiatrie
9. - 11. Oktober 2008, Göttingen, Germany - ZNS Tracer für die PET
Lanzenberger, 06.10.2008
Fortbildungsveranstaltung
Univ.Klinik f. Radiodiagnostik; AKH Wien, Austria - Neuroimaging in addiction: resolved issues and new challenges
Lanzenberger, 30.08.2008
Target Expert Meeting (TEM)
21st ECNP Congress, 30.8. - 3.9.2008, Barcelona, Spain - Does progesterone regulate the serotonergic neurotransmission in men?
Lanzenberger, 14.07.2008
50th Anniversary of CINP, Symposiums "The role of 5-HT1A receptors in treatment and understanding of depression and anxiety disorders"
Collegium Internationale of Neuro-Psychopharmacologicum (CINP)
26th CINP Congress, July 13 - 17, 2008, Munich, Germany - Wie Steroidhormone die Neurotransmission des Gehirn beeinflussen
Lanzenberger, 23.04.2008 Sitzung in der Gesellschaft der Ärzte, Wien, Austria - Sexualhormone und Entwicklung im Bereich des Gehirns
Lanzenberger, 02.04.2008
Ringvorlesung der Stabsstelle GENDER Mainstreaming, SS 2008 (902082)
MUW, Vienna, Austria - Multimodale und Multitracer Studien mit PET und fMRT
Lanzenberger, 03.03.2008
WINTERSEMINAR "BIOLOGISCHE PSYCHIATRIE", 3.- 7. März 2008, Oberlech, Austria - PET Auswertung bei psychiatrischen Studie
Savli, 03.03.2008
WINTERSEMINAR "BIOLOGISCHE PSYCHIATRIE", 3.- 7. März 2008, Oberlech, Austria - Multimodal imaging using PET and functinonal MRI reveals inverse relation between serotonin-1A receptor binding and neural activation
Lanzenberger, 12.01.2008
Radioactive Isotopes in Clinical Medicine and Research
28th International Symposium, January 9-12, 2008, Bad Hofgastein, Austria
Talks 2007
- Biologie der Angststörungen
Lanzenberger, 29.11.2007
Wissenschaftliches Seminar
Universitätsklinik für Psychiatrie, MUW, Austria - Anwendungen von PET in der Psychiatrie, Teil 2
Lanzenberger, 21.11.2007
Department of Nuclear Medicine, MUW, Vienna, Austria - Anwendungen von PET in der Psychiatrie, Teil 1
Lanzenberger, 14.11.2007
Department of Nuclear Medicine, MUW, Vienna, Austria - Kann man die Angst im Gehirn darstellen?
Lanzenberger, 09.11.2007
9. Tagung der Österreichischen Gesellschaft für Neuropsychopharmakologie und Biologische Psychiatrie (ÖGBP), Wien, Austria - Advances in NeuroImaging - Methodische Entwicklungen im Bereich Neuroimaging
Lanzenberger, 08.11.2007
Satellitenworkshop, Sponsor: Lundbeck
Collegium Internationale of Neuro-Psychopharmacologicum (CINP)
9. Tagung der Österreichischen Gesellschaft für Neuropsychopharmakologie und Biologische Psychiatrie (ÖGBP), Wien, Austria - How sex hormones influence the brain in men and women
Lanzenberger, 02.06.2007
2nd International Congress of Gender Medicine, June 2 - 3, 2007, Vienna, Austria - Serotonin 1A receptor level affects neural activation revealed by combining PET and functional MRI
Lanzenberger, 18.04.2007
2nd International Congress of Biological Psychiatry, April 17-21, 2007, Santiago de Chile, Chile - Wie viel Gehirn braucht der Affekt? Bildgebende Verfahren u. affektive Symptome bei Schizophrenie
Lanzenberger, Kasper 13.04.2007
Grazer Psychosentage, 13.-14.4.2007, Graz, Österreich - Kombinierte fMRT/PET des monoaminergen Systems bei psychiatrischen Störungen
Lanzenberger, 23.03.2007
51. Jahrestagung der Deutsche Gesellschaft für Klinische Neurophysiologie und Funktionelle Bildgebung (DGKN), München, 21.-25.3.2007 - Multimodal NeuroImaging of the serotonergic system using PET and fMRI
Lanzenberger, 13.03.2007
WINTERSEMINAR "BIOLOGISCHE PSYCHIATRIE", 13. März 2007, Oberlech, Austria - Ist bei Angsterkrankungen die serotonerge Inhibition reduziert? - Eine PET Studie mit [11C]WAY-100635
Lanzenberger, 26.01.2007
Jahrestagung der Österreichischen Gesellschaft für Nuklearmedizin, 25. - 27. Januar 2007, Linz, Austria